vs
Side-by-side financial comparison of Sintx Technologies, Inc. (SINT) and 60 DEGREES PHARMACEUTICALS, INC. (SXTP). Click either name above to swap in a different company.
60 DEGREES PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($303.4K vs $290.0K, roughly 1.0× Sintx Technologies, Inc.). 60 DEGREES PHARMACEUTICALS, INC. runs the higher net margin — -474.2% vs -763.8%, a 289.6% gap on every dollar of revenue. On growth, 60 DEGREES PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (25.6% vs -46.5%). 60 DEGREES PHARMACEUTICALS, INC. produced more free cash flow last quarter ($-1.8M vs $-2.4M). Over the past eight quarters, 60 DEGREES PHARMACEUTICALS, INC.'s revenue compounded faster (69.4% CAGR vs -35.0%).
Sintx Technologies, Inc. is an advanced materials company specializing in R&D and manufacturing of high-performance silicon nitride and other technical ceramic products. It serves key segments including medical implants, aerospace & defense, industrial wear components, and electric vehicle applications, with core markets across North America, Europe and Asia-Pacific.
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
SINT vs SXTP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $290.0K | $303.4K |
| Net Profit | $-2.2M | $-1.4M |
| Gross Margin | 64.8% | 60.2% |
| Operating Margin | -799.3% | -632.0% |
| Net Margin | -763.8% | -474.2% |
| Revenue YoY | -46.5% | 25.6% |
| Net Profit YoY | -30.7% | 29.7% |
| EPS (diluted) | $-0.50 | $-8.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $290.0K | $303.4K | ||
| Q3 25 | $208.0K | $437.6K | ||
| Q2 25 | $151.0K | $100.9K | ||
| Q1 25 | $369.0K | $163.6K | ||
| Q4 24 | $542.0K | $241.6K | ||
| Q3 24 | $799.0K | $135.3K | ||
| Q2 24 | $859.0K | $125.0K | ||
| Q1 24 | $687.0K | $105.7K |
| Q4 25 | $-2.2M | $-1.4M | ||
| Q3 25 | $-3.5M | $-2.3M | ||
| Q2 25 | $-2.3M | $-1.7M | ||
| Q1 25 | $-2.3M | $-1.9M | ||
| Q4 24 | $-1.7M | $-2.0M | ||
| Q3 24 | $-6.2M | $-2.2M | ||
| Q2 24 | $-2.2M | $-4.2M | ||
| Q1 24 | $-886.0K | $430.5K |
| Q4 25 | 64.8% | 60.2% | ||
| Q3 25 | 44.7% | -22.9% | ||
| Q2 25 | 37.7% | 50.4% | ||
| Q1 25 | 33.3% | 55.2% | ||
| Q4 24 | 71.6% | 51.1% | ||
| Q3 24 | 73.7% | 17.4% | ||
| Q2 24 | 73.9% | 28.3% | ||
| Q1 24 | 67.5% | 38.1% |
| Q4 25 | -799.3% | -632.0% | ||
| Q3 25 | -1613.0% | -531.4% | ||
| Q2 25 | -1764.9% | -1590.0% | ||
| Q1 25 | -645.8% | -1168.4% | ||
| Q4 24 | -319.6% | -854.7% | ||
| Q3 24 | -802.0% | -1566.0% | ||
| Q2 24 | -315.5% | -3351.8% | ||
| Q1 24 | -465.4% | -1270.4% |
| Q4 25 | -763.8% | -474.2% | ||
| Q3 25 | -1701.4% | -529.3% | ||
| Q2 25 | -1535.1% | -1717.7% | ||
| Q1 25 | -621.1% | -1147.4% | ||
| Q4 24 | -312.7% | -846.3% | ||
| Q3 24 | -780.9% | -1596.4% | ||
| Q2 24 | -256.6% | -3339.0% | ||
| Q1 24 | -129.0% | 407.4% |
| Q4 25 | $-0.50 | $-8.26 | ||
| Q3 25 | $-3.46 | $-0.66 | ||
| Q2 25 | $-0.91 | $-1.25 | ||
| Q1 25 | $-1.29 | $-1.56 | ||
| Q4 24 | $17.04 | $-51.96 | ||
| Q3 24 | $-6.96 | $-2.92 | ||
| Q2 24 | $-3.61 | $-21.12 | ||
| Q1 24 | $-21.66 | $1.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $2.8M |
| Total DebtLower is stronger | — | $150.0K |
| Stockholders' EquityBook value | $2.9M | $3.5M |
| Total Assets | $9.5M | $5.4M |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | $2.8M | ||
| Q3 25 | $6.3M | $4.1M | ||
| Q2 25 | $4.3M | $2.0M | ||
| Q1 25 | $6.5M | $3.5M | ||
| Q4 24 | $3.6M | $3.4M | ||
| Q3 24 | $4.8M | $5.0M | ||
| Q2 24 | $4.6M | $1.6M | ||
| Q1 24 | $5.8M | — |
| Q4 25 | — | $150.0K | ||
| Q3 25 | — | $150.0K | ||
| Q2 25 | — | $150.0K | ||
| Q1 25 | — | $150.0K | ||
| Q4 24 | — | $150.0K | ||
| Q3 24 | — | $150.0K | ||
| Q2 24 | — | $150.0K | ||
| Q1 24 | — | $150.0K |
| Q4 25 | $2.9M | $3.5M | ||
| Q3 25 | $4.1M | $4.4M | ||
| Q2 25 | $4.0M | $2.4M | ||
| Q1 25 | $6.1M | $4.1M | ||
| Q4 24 | $3.9M | $4.0M | ||
| Q3 24 | $5.6M | $6.0M | ||
| Q2 24 | $8.8M | $3.0M | ||
| Q1 24 | $9.9M | $7.2M |
| Q4 25 | $9.5M | $5.4M | ||
| Q3 25 | $11.4M | $6.7M | ||
| Q2 25 | $9.2M | $4.2M | ||
| Q1 25 | $11.4M | $6.0M | ||
| Q4 24 | $9.4M | $5.8M | ||
| Q3 24 | $11.3M | $7.4M | ||
| Q2 24 | $15.3M | $4.3M | ||
| Q1 24 | $17.6M | $8.4M |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.03× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 0.04× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.05× | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.3M | $-1.7M |
| Free Cash FlowOCF − Capex | $-2.4M | $-1.8M |
| FCF MarginFCF / Revenue | -822.8% | -584.2% |
| Capex IntensityCapex / Revenue | 14.5% | 26.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-7.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.3M | $-1.7M | ||
| Q3 25 | $-2.5M | $-2.1M | ||
| Q2 25 | $-2.4M | $-1.5M | ||
| Q1 25 | $-1.3M | $-1.6M | ||
| Q4 24 | $-1.1M | $-1.6M | ||
| Q3 24 | $-2.6M | $-1.7M | ||
| Q2 24 | $-2.2M | $-1.2M | ||
| Q1 24 | $-2.7M | $-1.1M |
| Q4 25 | $-2.4M | $-1.8M | ||
| Q3 25 | $-2.6M | $-2.1M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | $-1.4M | $-1.6M | ||
| Q4 24 | $-1.3M | — | ||
| Q3 24 | $-2.6M | $-1.7M | ||
| Q2 24 | $-2.6M | — | ||
| Q1 24 | $-2.9M | — |
| Q4 25 | -822.8% | -584.2% | ||
| Q3 25 | -1250.5% | -484.2% | ||
| Q2 25 | — | -1483.6% | ||
| Q1 25 | -368.6% | -978.3% | ||
| Q4 24 | -234.3% | — | ||
| Q3 24 | -323.0% | -1252.8% | ||
| Q2 24 | -299.7% | — | ||
| Q1 24 | -423.1% | — |
| Q4 25 | 14.5% | 26.3% | ||
| Q3 25 | 40.4% | 2.3% | ||
| Q2 25 | 0.0% | 46.9% | ||
| Q1 25 | 16.0% | 1.6% | ||
| Q4 24 | 26.9% | — | ||
| Q3 24 | 1.4% | 10.2% | ||
| Q2 24 | 41.8% | — | ||
| Q1 24 | 25.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -2.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
